Accordingly, the ability of NGAL to predict AKI on the first day of AmB administration was significantly higher than serum creatinine in hematologic–oncologic patients with an area under the curve (AUC) = 0.765 and 95% confidence interval (CI) = 0.59 to 0.96 [44]. The gene discussed is LCN2; the disease is acute kidney injury.